Table 1 Baseline demographic and clinical characteristics of the intention-to-treat population (N = 59)
Overall N = 59 | Bath1 N = 19 | Bath2 N = 21 | Control N = 19 | P | |
|---|---|---|---|---|---|
Gender (female/male) | 29/30 | 5/14 | 14/7 | 10/9 | 0.04*a |
Age (years) | 57.6 (9.6) | 60.2 (6.7) | 57.1 (10.0) | 55.5 (11.4) | 0.32 |
Patients taking antihypertensive medication (n) | 33 (55.9 %) | 11 (57.9 %) | 7 (33.3 %) | 15 (78.9 %) | 0.02*a |
No CVRF (n) | 2 | 0 | 2 | 0 | 0.46a |
1–2 CVRF (n) | 32 | 9 | 13 | 10 | |
≥3 CVRF (n) | 22 | 9 | 5 | 8 | |
CVD (n) | 3 | 1 | 1 | 1 | |
Smoking status (smoker/non-smoker) | 9/50 (15 %) | 1/18 (5 %) | 4/17 (19 %) | 4/15 (21 %) | 0.33a |
SBP (mm Hg) | 145.2 (10.2) | 147.2 (7.8) | 143.8 (12.3) | 144.8 (9.9) | 0.55 |
DBP (mm Hg) | 90.1 (8.5) | 91.8 (8.4) | 90.5 (9.9) | 88.1 (7.0) | 0.42 |
BMI (kg/m2) | 29.5 (5.7) | 29.9 (5.3) | 27.4 (5.3) | 31.3 (5.9) | 0.08 |
Waist circumference (cm) | 102.0 (13.0) | 106.0 (14.0) | 98.0 (13.0) | 103.0 (11.0) | 0.20 |
Cholesterol total (mg/dl) (50–200) | 226.0 (36.0) | 219.0 (38.0) | 230.0 (35.0) | 227.0 (36.0) | 0.63 |
LDL (mg/dl) (<160) | 138.0 (33.0) | 135.0 (33.0) | 143.0 (31.0) | 137.0 (35.0) | 0.72 |
HDL (mg/dl) (>40) | 48.0 (15.0) | 47.0 (13.0) | 51.0 (15.0) | 44.0 (15.0) | 0.28 |
LDL/HDL Quotient (<3) | 3.2 (1.3) | 2.9 (0.9) | 3.1 (1.5) | 3.5 (1.5) | 0.38 |
Triglyceride (mg/dl) (<150) | 153.0 (88.0) | 168.0 (107.0) | 126.0 (56.0) | 168.0 (95.0) | 0.22 |
CRP (mg/l) (0–5) | 2.7 (2.3) | 2.5 (2.3) | 2.3 (2.3) | 3.3 (2.3) | 0.36 |
Fasting blood glucose (mg/dl) (70–110) | 99.0 (23.0) | 110.0 (30.0) | 90.0 (18.0) | 95.0 (15.0) | 0.02* |